A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
Clinical trial NCT02263040 · COMPLETED
Trial details
- NCT number
- NCT02263040
- Sponsor
- Mount Sinai Hospital, Canada
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-07-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.